Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Stabilis Solutions Announces Third Quarter 2026 Results (Accesswire) +++ STABILIS SOLUTIONS Aktie -3,69%

TRANSMEDICS Aktie

 >TRANSMEDICS Aktienkurs 
65.36 EUR    +8.6%    (TradegateBSX)
Ask: 65.14 EUR / 50 Stück
Bid: 64.42 EUR / 50 Stück
Tagesumsatz: 320 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
TRANSMEDICS Aktie über LYNX handeln
>TRANSMEDICS Performance
1 Woche: -3,3%
1 Monat: -12,1%
3 Monate: -14,4%
6 Monate: -30,0%
1 Jahr: -44,4%
laufendes Jahr: -42,0%
>TRANSMEDICS Aktie
Name:  TRANSMEDICS GROUP
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US89377M1099 / A2PH5P
Symbol/ Ticker:  8T8 (Frankfurt) / TMDX (NASDAQ)
Kürzel:  FRA:8T8, ETR:8T8, 8T8:GR, NASDAQ:TMDX
Index:  -
Webseite:  https://www.transmedics.c..
Profil:  TransMedics Group, Inc. is a commercial-stage medical technology company focused on organ transplant therapy. The company develops and commercializes the Organ Care System (OCS), a platform designed to preserve, monitor, and assess donor organs outsi..
>Volltext..
Marktkapitalisierung:  2057.32 Mio. EUR
Unternehmenswert:  2401.65 Mio. EUR
Umsatz:  594.89 Mio. EUR
EBITDA:  105.04 Mio. EUR
Nettogewinn:  135 Mio. EUR
Gewinn je Aktie:  3.94 EUR
Schulden:  772.21 Mio. EUR
Liquide Mittel:  420.65 Mio. EUR
Operativer Cashflow:  129.86 Mio. EUR
Bargeldquote:  4.81
Umsatzwachstum:  29.78%
Gewinnwachstum:  118.35%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  TRANSMEDICS
Letzte Datenerhebung:  04.11.26
>TRANSMEDICS Kennzahlen
Aktien/ Unternehmen:
Aktien: 34.68 Mio. St.
Frei handelbar: 96.14%
Leerverk. Aktien: 25.37%
Rückkaufquote: -0.51%
Mitarbeiter: 898
Umsatz/Mitarb.: 0.6 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 48.52%
Bewertung:
KGV: 17.61
KGV lG: 45.24
KUV: 4.02
KBV: 4.53
PEG-Ratio: 0.17
EV/EBITDA: 22.86
Rentabilität:
Bruttomarge: 57.75%
Gewinnmarge: 22.69%
Operative Marge: 12.21%
Managementeffizenz:
Gesamtkaprendite: 12.88%
Eigenkaprendite: 36.28%
>TRANSMEDICS Peer Group
Gesundheit, Lungen- & Atemwegserkrankungen/ -behandlung, Medizinprodukte & -technik/ Implantate/ Wundpflege, Lebererkrankungen & -behandlung/ Hepatitis, Herz-Kreislauf- Behandlung/ Kardiologie
 
04.11.26 - 21:15
 Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
 
TMDX's OCS technology, robust pipeline and global expansion support growth prospects, but margin pressures and rising investments remain key concerns....
30.10.26 - 21:06
 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
 
ANDOVER, Mass., Oct. 30, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on October 28, 2026, the......
29.10.26 - 22:06
 TransMedics to Present at Upcoming Investor Conferences (PR Newswire)
 
ANDOVER, Mass., Oct. 29, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in......
27.10.26 - 12:01
 TransMedics selects Gogo Galileo HDX for nationwide organ transport fleet (GlobeNewswire EN)
 
Reliable, high-performance connectivity will support time-critical transport and monitoring of donor organs for transplants aboard 22 Embraer Phenom 300E aircraft Reliable, high-performance connectivity will support time-critical transport and monitoring of donor organs for transplants aboard 22 Embraer Phenom 300E aircraft...
22.10.26 - 22:09
 TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026 (PR Newswire)
 
ANDOVER, Mass., Oct. 22, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial......
29.09.26 - 19:12
 TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too? (Fool)
 
Weill's acquisition increased his direct holdings to 16,392 shares, valued at $1.4 million at recent market prices, amid a 30% decline in the stock over the past year....
26.09.26 - 07:46
 Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
 
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the......
15.09.26 - 16:48
 TransMedics auf Global Healthcare Conference 2026: Expansionskurs wird skizziert (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
15.09.26 - 01:01
 Insiderhandel: Aufsichtsrat kauft Aktien von TransMedics Group im Wert von 109058 USD (Insiderkauf)
 
Weill, David - Aufsichtsrat - Tag der Transaktion: 2026-09-11...
14.09.26 - 23:06
 TransMedics auf Morgan Stanley Konferenz: Wachstumsplan setzt auf Logistik (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
10.09.26 - 22:24
 TransMedics appoints new finance chief (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.09.26 - 22:06
 TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook (PR Newswire)
 
ANDOVER, Mass., Sept. 10, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), the global leader in portable warm perfusion for donor organs for transplantation, today announced the appointment of Fernando Araujo as Chief Financial Officer, effective September 21,......
07.09.26 - 21:09
 Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
 
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the......
03.09.26 - 21:15
 Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure? (Zacks)
 
TransMedics' rapid revenue growth and cheaper valuation face rising margin pressure as heavy investment raises execution risks....
03.09.26 - 19:00
 Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report? (Zacks)
 
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
01.09.26 - 04:54
 Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX (PR Newswire)
 
NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX). If you currently own shares of TransMedics Group stock,......
31.08.26 - 22:09
 TransMedics to Present at Upcoming September Investor Conferences (PR Newswire)
 
ANDOVER, Mass., Aug. 31, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in......
29.08.26 - 04:03
 TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX (PR Newswire)
 
NEW YORK and NEW ORLEANS, Aug. 28, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into TransMedics Group, Inc. (NasdaqGM: TMDX)......
21.08.26 - 13:51
 Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX (PR Newswire)
 
NEW YORK, Aug. 21, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX). If you currently own shares of TransMedics Group stock,......
18.08.26 - 15:57
 Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX (PR Newswire)
 
NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX). If you currently own shares of TransMedics Group stock,......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Bei der Erzählung jeder ungerechten Handlung, wer auch ihr Opfer oder wo auch ihr Schauplatz sei, gerät mein Herz in Flammen, als ob die Wirkung auf mich zurückfiele. - Jean-Jacques Rousseau
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!